All the Latest

Our Recent Posts

Rise of PARP Inhibitors: Clovis Oncology vs Tesaro

The Evolution of Control

Aurinia Combating Lupus Nephritis

In the News: French Clinical Trial Gone Wrong

A Step Ahead of Medicine: Allergan, Plc

Kite Pharma's Revolutionary Cancer Treatment

Back from the Grave: AMD

Tesla reminiscent of Amazon in 1999?

Tags

No tags yet.

Rise of PARP Inhibitors: Clovis Oncology vs Tesaro

PARP inhibitors are a new class of drugs found to suppress the progression of certain cancers such as ovarian, in recurrent platinum-sensiti

Back from the Grave: AMD

Considering AMD’s substantial growth in 2016, investors have become wary if AMD could continue it’s growth in 2017. AMD Ryzen chips have sho

Tesla reminiscent of Amazon in 1999?

Tesla's stock is purely valued for the company it could be and does not reflect the financial uncertainties and the extraordinary debt i

Value Behind the Fear: Gilead Sciences

Gilead's pipeline has a newly approved drug for treating HBV (Vemlidy) and phase 3 trials in NASH. Both these diseases represent huge op

Home: Blog

Home: GetSubscribers_Widget

Contact US

You have any questions or need to contact us about something? Reach out, we’d be happy to hear from you!

Home: Contact